Bonit Capital

Bonit Capital is a Swedish family-owned investment company that deploys capital across four asset classes: private equity, real assets, liquid assets and sustainable innovation. Its private equity activity concentrates on European lower- to mid-market buyouts and growth equity, where the stated criterion is backing entrepreneurial teams with sector expertise and distinctive market access. Real assets comprise European commercial and residential property; liquid assets cover mandates spanning listed equities and fixed income. The firm describes a long-term ownership horizon and an orientation toward opportunities capable of persisting across generations, a framing consistent with family-office capital rather than a fund with a fixed life.

Healthcare is the company's point of origin. A cornerstone holding is Elekta AB, the medical technology company founded by Laurent Leksell, and the portfolio's technical interests - diagnostics, biotechnology, data-driven life science and healthcare more broadly - trace to that base. Through Leksell Social Ventures, a wholly owned subsidiary, the firm pursues social outcome models alongside early investments in diagnostics, biotech and data-driven life science. Sustainable innovation investments sit within the wider mandate.

Geographic presence is stated as Sweden and Europe. Founding year, team size and check size are not disclosed. Candidates evaluating the firm should note the mix of operating categories it spans - from buyouts and property to listed securities and early-stage life science - and the combination of an entrepreneurial, impact-conscious approach with permanent capital.